Predictors of poor CD4 and weight recovery in HIV-infected children initiating ART in South Africa

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Zanoni, Brian C ^a,b,c   Phungula, Thuli ^c   Zanoni, Holly M ^c   France, Holly ^c   Cook, E Francis ^d   Feeney, Margaret E ^c,e  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCCORD HOSPITAL   (South Africa)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CHRONIC DIARRHEA; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SOUTH AFRICA; CD4 LYMPHOCYTE COUNT; DIARRHEA; IMMUNOLOGY; INFANT; PATHOLOGY; PROGNOSIS; RISK FACTOR; STATISTICAL MODEL; TREATMENT FAILURE; TREATMENT OUTCOME; VIROLOGY; WEIGHT GAIN;

HUMAN IMMUNODEFICIENCY VIRUS;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIARRHEA; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LOGISTIC MODELS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 84858401020     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033611     Document Type: Article

References (34)

1. Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, et al. (2008) Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS patient care and STDs 22: 245-251.
2. Banerjee T, Pensi T, Banerjee D, Grover G, (2010) Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India. Annals of tropical paediatrics 30: 27-37.
3. Hainaut M, Ducarme M, Schandene L, Peltier CA, Marissens D, et al. (2003) Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. The Pediatric infectious disease journal 22: 62-69.
4. Diniz LM, Maia MM, Camargos LS, Amaral LC, Goulart EM, et al. (2011) Impact of HAART on growth and hospitalization rates among HIV-infected children. Jornal de pediatria 87: 131-137.
5. Guillen S, Ramos JT, Resino R, Bellon JM, Munoz MA, (2007) Impact on weight and height with the use of HAART in HIV-infected children. The Pediatric infectious disease journal 26: 334-338.
6. Weigel R, Phiri S, Chiputula F, Gumulira J, Brinkhof M, et al. (2010) Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi. Tropical medicine & international health: TM & IH 15: 934-944.
7. Rosenblatt HM, Stanley KE, Song LY, Johnson GM, Wiznia AA, et al. (2005) Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection. The Journal of infectious diseases 192: 445-455.
8. Rouet F, Fassinou P, Inwoley A, Anaky MF, Kouakoussui A, et al. (2006) Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS 20: 2315-2319.
9. Kovacs A, Montepiedra G, Carey V, Pahwa S, Weinberg A, et al. (2005) Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response. The Journal of infectious diseases 192: 296-302.
10. Kekitiinwa A, Lee KJ, Walker AS, Maganda A, Doerholt K, et al. (2008) Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland. Journal of acquired immune deficiency syndromes 49: 384-392.
11. Machado DM, Gouvea Ade F, Cardoso MR, Beltrao SV, Cunegundes KS, et al. (2007) Factors associated with clinical, immunological and virological responses in protease-inhibitor-experienced Brazilian children receiving highly active antiretroviral therapy containing lopinavir-ritonavir. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 11: 16-19.
12. Lederman MM, Calabrese L, Funderburg NT, Clagett B, Medvik K, et al. (2011) Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. The Journal of infectious diseases 204: 1217-1226.
13. Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, et al. (2008) Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS 22: 2493-2499.
14. Bong CN, Yu JK, Chiang HC, Huang WL, Hsieh TC, et al. (2007) Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS 21: 1805-1810.
15. Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, et al. (2010) Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC pediatrics 10: 33.
16. Callens SF, Shabani N, Lusiama J, Lelo P, Kitetele F, et al. (2009) Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. The Pediatric infectious disease journal 28: 35-40.
17. Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME, (2011) Risk Factors Associated with Increased Mortality among HIV Infected Children Initiating Antiretroviral Therapy (ART) in South Africa. PloS one 6: e22706.
18. Newell ML, Patel D, Goetghebuer T, Thorne C, (2006) CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? The Journal of infectious diseases 193: 954-962.
19. South Africa National Department of HealthSouth African National Department of Health, editor (2004) National Antiretroviral Treatment Guidelines Johannesberg Minuteman Press.
20. South Africa National Department of HealthSouth African National Department of Health, editor (2010) Guidelines for the Management of HIV in Children. Johannesberg Minuteman Press.
21. World Health Orginization (2010) Antiretriviral Therapy for HIV Infection in Infants and Children: Towards Universal Access Geneva, Switzerland World Health Orginization.
22. World Health Organization (2006) Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a public health approach Geneva, Switzerland World Health Orginization.
23. Dillingham RA, Pinkerton R, Leger P, Severe P, Guerrant RL, et al. (2009) High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study. The American journal of tropical medicine and hygiene 80: 1060-1064.
24. Zulu I, Hassan G, Njobvu RNL, Dhaliwal W, Sianongo S, et al. (2008) Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea. BMC infectious diseases 8: 156.
25. Kugathasan S, Willis J, Dahms BB, O'Riordan MA, Hupertz V, et al. (1998) Intrinsic hyperreactivity of mucosal T cells to interleukin-2 in pediatric Crohn's disease. The Journal of pediatrics 133: 675-681.
26. Penedo-Pita M, Peteiro-Cartelle J, (1991) Increased serum levels of interleukin-2 and soluble interleukin-2 receptor in celiac disease. Journal of pediatric gastroenterology and nutrition 12: 56-60.
27. Salvatore S, Hauser B, Devreker T, Arrigo S, Vandenplas Y, (2008) Chronic enteropathy and feeding in children: an update. Nutrition 24: 1205-1216.
28. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature medicine 12: 1365-1371.
29. Hunt PW, Brenchley J, Sinclair E, McCune JM, Roland M, et al. (2008) Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. The Journal of infectious diseases 197: 126-133.
30. Eisenhut M, (2007) Amplification of HIV-induced depletion of CD4 T cells of gut-associated lymphoid tissue by enteric bacteria. AIDS 21: 1227-1228.
31. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. Journal of virology 77: 11708-11717.
32. Naidoo R, Rennert W, Lung A, Naidoo K, McKerrow N, (2010) The influence of nutritional status on the response to HAART in HIV-infected children in South Africa. The Pediatric infectious disease journal 29: 511-513.
33. Bandyopadhyay A, Bhattacharyya S, (2008) Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy. Annals of tropical paediatrics 28: 279-285.
34. Barreiro P, Soriano V, Casas E, Gonzalez-Lahoz J, (2002) Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides. AIDS 16: 245-249.